Does it excite you to work with process and SOP improvements, GCP and quality compliance and advisory, and cross-functional collaboration? Do you have experience with clinical trial processes and compliance? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
We offer exciting responsibilities:
Your profile
You thrive in a role where structure meets curiosity, and you're motivated by turning complex regulatory requirements into clear, practical processes. You bring a strong sense of ownership, work well across functions, and are comfortable navigating both the details and the bigger compliance picture.
Your new team
Clinical Oversight and Compliance is a newly established department, anchored in Clinical Operations and growing to support all of Development. Our team of 8 specializes in processes, compliance, quality risk management, sponsor oversight, and clinical technologies and as we expand, so does our impact across the organization. We work as one team, with an informal atmosphere built on knowledge sharing and a shared drive for excellence.
Let’s bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold
Interested in bonding with us? Then please apply no later than August 30 , 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact Head of Clinical Oversight and Compliance, Helle Maach-Møller on hmaachmoller@zealandpharma.com
From August 3rd to August 14th, 2026, please contact Head of Clinical Operations Tove Kristensen Stryhn on TStryhn@zealandpharma.com
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced datadriven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com
#LI-Onsite
At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.
Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.
We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
